
    
      This is a 2-part, randomized, double-blind, placebo-controlled, single-dose-escalation (Part
      1) and multiple-dose-escalation (Part 2) study to evaluate the safety, tolerability, PK, and
      PD of AC0058TA administered orally to healthy subjects. Part 1 of the study will also to
      evaluate the effect of food on the pharmacokinetics of a single oral dose of AC0058TA.
    
  